TABLE 1
Summary of Cancer Screening Recommendations for Low-Risk Patients
MARCH 15, 2001 / VOLUME 63, NUMBER 6
www.aafp.org/afp AMERICAN FAMILY PHYSICIAN 1103
Medical organization Screening recommendations
Breast cancer
MAMMOGRAPHY
AAFP
Every 1 to 2 years, ages 50 to 69; counsel women ages 40 to 49 about potential
risks and benefits of mammography
and clinical breast examination.
ACOG Every 1 to 2 years starting at age 40, yearly after age 50
ACS Annually after age 40
AMA Every 1 to 2 years in women ages 40 to 49; annually beginning at age 50
CTFPHC Every 1 to 2 years, ages 50 to 59
NIH
Data currently available do not warrant a universal recommendation for
mammography for women in their
40s; each woman should decide for herself whether to undergo mammography.
USPSTF Every 1 to 2 years, ages 50 to 69
CLINICAL BREAST EXAMINATION
AAFP Every 1 to
2 years, ages 50 to 69; counsel women ages 40 to 49 about potential risks and
benefits of
mammography and clinical breast examination.
ACOG Yearly (or
as appropriate) general health evaluation that includes examination to detect
signs of premalignan
or malignant conditions
ACS Every 3 years, ages 20 to 39; yearly after age 40; monthly breast self-examination beginning at age 20
AMA Continuation of clinical breast examinations in asymptomatic women older than age 40
CTFPHC Yearly, ages 50 to 69
USPSTF Insufficient evidence to
recommend for or against using clinical breast examination alone; optional every
1 to 2 years, ages 50 to 69
Cervical cancer
AAFP Pap test at least every 3 years to women who have ever had sexual intercourse and who have a cervix
ACOG Annual Pap
test and pelvic examination beginning at age 18 or when sexually active; after 3
or more tests
with normal results, Pap test may be performed less frequently on physician’s
advice.
ACS
Pap test annually starting at age 18 or when sexually active; after 2 to 3
normal (negative) tests, continue at
discretion of physician.
AGS
Pap test every 3 years until age 70; in women of any age who have never had a
Pap test, screening with at
least 2 negative smears 1 year apart
AMA Annual Pap
test and pelvic examination starting at age 18 (or when sexually active); after
3 or more normal
annual Pap tests, the Pap test may be performed less frequently at the
physician’s discretion.
CTFPHC Pap test annually beginning at
age 18 or following initiation of sexual activity; after 2 normal Pap results,
perform Pap tests every 3 years to age 69.
USPSTF Pap test at least every 3 years
in women who have ever had sexual intercourse and who have a cervix;
discontinue regular testing after age 65 if Pap test results have been
consistently normal.
Colorectal cancer
AAFP No published standards or guidelines for low-risk patients
ACOG After age 50, annual FOBT (DRE should accompany pelvic examination); sigmoidoscopy every 3 to 5 years
ACS
After age 50, yearly FOBT plus flexible sigmoidoscopy and DRE every 5 years or
colonoscopy and DRE every
10 years or double-contrast barium enema and DRE every 5 to 10 years
AMA Annual FOBT beginning at age 50, and flexible sigmoidoscopy every 3 to 5 years beginning at age 50
AGA FOBT
beginning at age 59 (frequency not specified); sigmoidoscopy every 5 years,
double-contrast barium
enema every 5 to 10 years or colonoscopy every 10 years.
CTFPHC Insufficient evidence to
recommend using FOBT screening in the periodic health examination of individuals
older than age 40; insufficient evidence to recommend sigmoidoscopy in the
periodic health examination;
insufficient evidence to recommend screening with colonoscopy in the general
population
USPSTF After age 50, yearly FOBT and/or sigmoidoscopy (unspecified frequency for sigmoidoscopy)
Prostate cancer
AAFP No published standards or guidelines for low-risk patients
ACP-ASIM Physicians should describe
potential benefits and known harms of screening, diagnosis and treatment; listen
to the patient’s concerns, then individualize the decision to screen.
ACS, AUA Offer annual DRE and PSA
screening, beginning at age 50, to men who have at least a 10-year life
expectancy
and to younger men at high risk.
AMA Provide information regarding the risks and potential benefits of prostate screening.
CTFPHC, USPSTF DRE and PSA tests are not recommended for the general population.
Skin cancer
ACS
Cancer-related checkup, including skin examination every 3 years between ages 20
and 40, and every year
for anyone age 40 and older
AMA
Patients should talk to their physicians about the frequency of screening for
skin cancer (those at modestly
increased risk should see a primary care physician annually); skin
self-examination should be performed
monthly.
CTFPHC
Insufficient evidence to recommend for or against total-body skin examination or
self-examination; counsel on
avoiding sun exposure and wearing protective clothing.
USPSTF
Insufficient evidence to recommend for or against routine screening for skin
cancer by primary care clinicians
or counseling patients to perform periodic skin examination.
Testicular cancer
ACS Examine testicles as part of a cancer-related checkup.
CTFPHC Insufficient evidence to recommend routine examination of testes by physician or by patient selfexamination
USPSTF
Insufficient evidence to recommend for or against routine screening of
asymptomatic men in the general
population by physician examination or patient self-examination
DRE = digital rectal examination; FOBT = fecal occult blood testing; Pap = Papanicolaou; PSA = prostate-specific antigen.
ABBREVIATIONS FOR MEDICAL ORGANIZATIONS: AAFP = American Academy of Family Physicians; ACOG = American College of Obstetricians and
Gynecologists; ACP-ASIM = American College of Physicians-American Society of Internal Medicine; ACS = American Cancer Society; AGA
= American Gastroenterological Association; AGS = American Geriatrics Society; AMA = American Medical Association; AUA = American
Urological Association; CTFPHC = Canadian Task Force on Preventive Health Care; NIH = National Institutes of Health; USPSTF = U.S. Preventive
Services Task Force.